Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary ICD-10 code for Pyoderma Gangrenosum is L88, while the corresponding ICD-9 code is 686.01. These codes are essential for medical documentation, insurance billing, and tracking the clinical progression of Pyoderma Gangrenosum within healthcare systems. What exactly is Pyoderma Gangrenosum? Pyoderma Gangrenosum is a rare, inflammatory skin condition characterized by the development of painful, rapidly enlarging ulcers, often with purplish or violaceous overhanging borders.
The primary ICD-10 code for Pyoderma Gangrenosum is L88, while the corresponding ICD-9 code is 686.01. These codes are essential for medical documentation, insurance billing, and tracking the clinical progression of Pyoderma Gangrenosum within healthcare systems.
Pyoderma Gangrenosum is a rare, inflammatory skin condition characterized by the development of painful, rapidly enlarging ulcers, often with purplish or violaceous overhanging borders. While it is classified as a neutrophilic dermatosis, the exact etiology of Pyoderma Gangrenosum remains complex, as it frequently presents alongside systemic conditions like inflammatory bowel disease, rheumatoid arthritis, or hematologic malignancies.
Accurate coding is vital for patients seeking specialized care. Because Pyoderma Gangrenosum can be misdiagnosed as an infection, clinicians use specific codes to ensure proper treatment pathways. The ICD-10-CM code L88 is the internationally recognized standard for Pyoderma Gangrenosum, replacing the older ICD-9-CM code 686.01. Understanding these codes helps the 39 members of the DiseaseMaps Pyoderma Gangrenosum community navigate their medical records and insurance claims more effectively.
Beyond the ICD-10 code, managing Pyoderma Gangrenosum requires a multidisciplinary approach due to its systemic nature. Clinical management often includes:
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.